Autolus Therapeutics Ltd reported $251.94M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AstraZeneca USD 26.14B 19.58B Dec/2025
Autolus Therapeutics Ltd USD 251.94M 7.31M Sep/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Novartis USD 24.24B 174M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Silence Therapeutics USD 0 0 Sep/2024